Related Experiment Videos
Recent developments in the treatment of infectious diseases. VI. Venereal diseases
Missouri Medicine
|February 1, 1972
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Reduction of "callbacks" to the ED due to discrepancies in plain radiograph interpretation.
The American journal of emergency medicine·1998
Purine nucleoside and nucleobase cell membrane transport in Giardia lamblia.
The Journal of eukaryotic microbiology·1993
Allopurinol in the treatment of American cutaneous leishmaniasis.
The New England journal of medicine·1992
Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis.
The Journal of laboratory and clinical medicine·1991
Antiprotozoal activity of 3'-deoxyinosine. Inverse correlation to cleavage of the glycosidic bond.
Biochemical pharmacology·1991
Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives.
Antimicrobial agents and chemotherapy·1990
Kratom in Clinical Practice: What Physicians Need to Know.
Missouri medicine·2026
The Forgotten Few: Pediatric-to-Adult Healthcare Transitions.
Missouri medicine·2026
Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.
Missouri medicine·2026
Not Just a Pediatric Condition: Down Syndrome Across the Lifespan.
Missouri medicine·2026
RNA virome comparison between sylvatic and urban-interface mosquitoes from Southeastern Brazil.
Frontiers in cellular and infection microbiology·2026
Mpox in the Republic of Korea from 2022 to June 2026: Epidemiological Trends and the First Clade Ib Case.
Public health weekly report·2026
Cardiac MRI-guided therapeutics in ischemic cardiomyopathy: impact on heart-team consensus and outcomes.
Frontiers in cardiovascular medicine·2026
Re-evaluating variability of circulating miR-122 in healthy volunteers: Implications for biomarker qualification in drug-induced liver injury.
British journal of clinical pharmacology·2026
MicroRNA-122 as a regulator and biomarker of liver disease.
Journal of molecular medicine (Berlin, Germany)·2026